Medizone Intl. (fka MZEIQ)

[Tane61]

MZEI unable to enter the healthcare disinfection market

... in 5+ years of trying so any suggestion that they could "change" the healthcare "sterilization industry" is surely rooted in fantasy rather than reality!

----------

THE REALITY:

Peroxide - Ozone sterilization technology was presented at the World Federation for Hospital Sterilization Sciences (WFHSS) 18th World Sterilization Congress on October 04-07, 2017 Bonn, Germany.

https://www.wfhssbonn2017.com/

-----

The Getinge Group paid US$7.5 Million in an Up-Front License Fee for global distribution rights (2015) to this same Peroxide - Ozone technology that the healthcare sterilization market is CLAMOURING for unlike MZEI who is trying to ram, UNSUCCESSFULLY, a Peroxide - Ozone product down the figurative throat of the TOTALLY DISINTERESTED healthcare environmental disinfection market hence their distribution fiasco/ZERO HEALTHCARE SALES!

----------

Those so blind they cannot see.I believe if any company was interested they would have bought the technology long ago.

----------

MZEI UNABLE TO MAKE ANY HOSPITAL SALES IN FIRST 5+ YEARS

TO DATE, NOT ONE (1) SALE TO A HOSPITAL NOR ONE (1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED, WORLDWIDE (The manufacture of the first production machine was announced back in April 2012)

----------

Going Concern

Our unaudited condensed interim consolidated financial statements included in this report on Form 10-Q have been prepared with the assumption that we will continue as a going concern. There is substantial doubt that we will be able to continue as a going concern. Through the date of this report on Form 10-Q, we have relied almost exclusively upon financing from the sale of our equity securities to sustain operations. Additional financing will be required if we are to continue as a going concern. If we do not obtain additional financing in the near term, we will be required to curtail or discontinue operations, or seek protection under U.S. bankruptcy laws. Even if additional financing becomes available, there can be no assurance that it will be on terms favorable to us. In any event, this additional financing will likely result in immediate and possibly substantial dilution to existing stockholders.

Forward-Looking Statements and Risks

The statements contained in this report on Form 10-Q that are not historical are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements discuss our expectations, hopes, beliefs, anticipations, commitments, intentions and strategies regarding the future. They may be identified by the use of the words or phrases that include “believes,” “expects,” “anticipates,” “should,” “plans,” “estimates,” and “potential,” among others. Forward-looking statements include, but are not limited to, statements contained in Management’s Discussion and Analysis of Financial Condition and Results of Operations regarding our financial performance, revenue and expense levels in the future and the sufficiency of existing liquidity to fund future operations and capital spending needs. Actual results could differ materially from the anticipated results or other expectations expressed in such forward-looking statements for the reasons detailed in our Annual Report on Form 10-K for the year ended December 31, 2016.

We believe that many of the risks discussed in our previously issued SEC filings are part of doing business in the industry in which we operate and will likely be present in all periods reported. The fact that certain risks are endemic to the industry does not lessen their significance. The forward-looking statements contained in this report are made as of the date of this report and we assume no obligation to update them or to update the reasons why actual results could differ from those projected in such forward-looking statements.

Among others, risks and uncertainties that may affect our business, financial condition, performance, development, and results of operations include:

·Rigorous government scrutiny and regulation of our products and planned products;
·Potential effects of adverse publicity regarding ozone and related technologies or industries;
·Failure to sustain or manage growth including the failure to continue to develop new products; and
·The potential inability to obtain needed financing or to obtain funding on terms favorable to us.